OLAGUNJU PETER (Chief Technical Officer) sold 8.8% of their position (2.79K shares) of TCR2 THERAPEUTICS INC. on the open market
Open‑market sale worth $3.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/9/2022ACC: 0000899243-22-038096
Officer· Chief Technical Officer
Since Jul 2021
-2.79K
Net shares
Net seller
$3.5K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.79K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.38K
Price / share
$1.28
Trade value
$1.77K
% of position
4.3%
12/7/2022
31.71K→30.33K
Common Stock
Direct
Shares
−1.41K
Price / share
$1.25
Trade value
$1.77K
% of position
4.6%
12/8/2022
30.33K→28.92K
Total
Net shares
−2.79K
Net value
-$3.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/7/2022 | S · Sale | −1.38K | $1.28 | $1.77K | 4.3% | 31.71K | 30.33K |
| Common Stock Direct | 12/8/2022 | S · Sale | −1.41K | $1.25 | $1.77K | 4.6% | 30.33K | 28.92K |
| Total | −2.79K | -$3.53K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned31.71K
Total
31.71K direct31.71K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 31.71K | Direct |
| Total | 31.71K | 31.71K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported